Interleukin-12 (IL-12) is a major pro-inflammatory cytokine, which promotes cell-mediated immunity and T H 1 differentiation. In vitro studies indicated suppression of IL-12 production by several stressrelated factors, but no effects of behavioral stress were shown on plasma IL-12 levels. Therefore, in the current study we (i) examined the in vivo effects of various behavioral and pharmacological stress paradigms on baseline plasma IL-12 levels; (ii) compared these in vivo findings to those obtained following in vitro stimulation of leukocytes from the same rats; and (iii) assessed potential sexual dimorphism in these outcomes. The findings indicated that plasma IL-12 levels were significantly reduced by social confrontation, wet-cage exposure, surgery, and the administration of corticosterone, epinephrine, or prostaglandin-E 2 . Notably, most in vivo impacts on plasma levels were not evident when assessed in vitro. The IL-12-reducing effects of wet-cage exposure, and of corticosterone and epinephrine administration, were significantly greater in males than in females, although females exhibited greater total corticosterone levels following stress. The duration of acute stressors predicted the degree of IL-12 reduction, but more prolonged stressors did not. Furthermore, seven days of alternating behavioral stressors reduced plasma IL-12 levels more than 14 days. These findings suggest animals' behavioral habituation to stress conditions, or a specific immune mechanism restricting the duration of IL-12 reduction. Overall, our findings indicate a generic and robust stress-induced reduction in plasma IL-12 levels, and suggest epinephrine, corticosterone, and prostaglandin-E 2 , as potential mediators that should be scrutinized in vivo in the context of natural physiological stress responses.
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Introduction
Interleukin-12 (IL-12) is an important pro-inflammatory cytokine and a promoter of cell-mediated immunity. IL-12 is known to promote T H 1 differentiation (i) by stimulating NK and CD4 + T cells to produce interferon-c (IFN-c); (ii) by stimulating the proliferation of undifferentiated T cells (Kubin et al., 1994; Trinchieri, 2003) ; and (iii) by supporting the expansion and activation of pre-activated T H 1 cells (Perussia et al., 1992) . IL-12 also coordinates between the innate and the adaptive immune systems by (i) directly stimulating leukocytes of both immune arms, including NK, T and B cells, and (ii) by stimulating NK cells of innate immunity (Trinchieri, 2003; Yoo et al., 2002) to enhance cytotoxicity and/or proliferation of CTLs and B cells (Curtsinger et al., 2003; Metzger et al., 1997) . Finally, IL-12 has been shown to reduce tumor angiogenesis (Kanegane et al., 1998) by elevating CXC chemokine levels (e.g., IP-10 and Mig). Given the prevalent immunostimulatory and anti-angiogenic effects of IL-12, this cytokine is considered an important anti-tumor agent, in addition to being a prominent indicator of the T H 1/T H 2 cytokine balance. Environmental and physiological stressors were shown to modulate numerous immune and inflammatory indices related to IL-12 levels. Surgical stress was shown to suppress CMI in humans (Bartal et al., 2010; Ogawa et al., 2000) and in animals (Glasner et al., 2010) , as indicated by reduced number and activity of T H cells, CTLs, and NK cells, and by reduced expression of Fas ligand and CD11a on NK cells. Acute restraint stress was shown to reduce serum levels of IFN-c and to suppress the expression of IFN-c inducible genes, such as IP-10 (IFN-c-inducible protein 10) and iNOS (inducible nitric oxide synthase). These effects were suggested to be mediated, at least partly, by reduced in vivo IL-12 levels (Curtin et al., 2009 ), but no direct evidence is available as of yet. In vitro studies suggested that several stress factors, including PGE 2 (van der Pouw Kraan et al., 1995) , catecholamines (Panina-Bordignon et al., 1997) , and glucocorticoids (Elenkov et al., 1996) , could reduce IL-12 production by leukocytes stimulated by biological response modifiers (e.g., LPS).
Chronic stress was repeatedly shown to suppress CMI and T H 1 indices, and to promote cancer progression. For example, caregiv-
